Shares in Britain’s Games Workshop fell as much as 6.5% after the company warned that volatility in global energy markets linked to the Iran war could lift plastic raw-material costs by about £2 million. It also said U.S. tariffs are expected to add an annualised cost of around £13 million. While the Warhammer maker plans to offset part of the impact through price increases and operational changes, the cost pressures overshadowed its record annual profit.

KAITO rose 9.59% to USD 1.28 on USD 82.81M volume. Attention is elevated, while RSI7 at 85.48 and a July 20 unlock raise follow-through risk.

HYPE trades near USD 56.27, down 6.62% in 24 hours, as social attention stays elevated, perps open interest softens and protocol revenue remains strong.

Akedo rose 30.96% to USD 0.00443 on USD 56.97M of spot volume. Airdrop attention and an August 5 buyback-verification deadline supported visibility, while RSI readings remain extreme.

Bitcoin trades near USD 63,278, down 3.00% in 24 hours, as a USD 156.49M BTC liquidation pulse hit long positions and spot turnover rose.

Jared Kushner’s Affinity Partners sold 25% of its holding in Israel’s Phoenix Financial (TASE: PHOE), raising NIS 1.05 billion and cutting its stake from about 9.9% to 7.4%. The transaction was completed at a 4% discount to the day’s reference price and was described as a financial sale that does not change control or operations. Phoenix Financial is an insurance group listed on the Tel Aviv Stock Exchange, and the deal was a shareholder secondary-market trade rather than a company-led transaction.

Varun Beverages, PepsiCo’s largest bottling partner in India, reported a 15.5% year-on-year rise in consolidated net profit in the second quarter to 15.21 billion rupees as volumes increased. Revenue from operations grew 20.8% to 86.51 billion rupees, while consolidated sales volume climbed 19.8% and international volumes surged 38.4%. The company said early stocking of key raw materials and a higher mix of low- and no-sugar products helped protect margins in India, and it has extended its exclusive India bottling agreement with PepsiCo by 10 years. The results point to strong end-market demand for soft drinks, offering tangible support to upstream sugar raw materials.

Sakar Healthcare reported Q1 FY2026-27 net profit of Rs 10.28 crore, up 120% year on year. Revenue from operations rose 38% to Rs 72.97 crore. The company said it executed more than 65 oncology product contracts during the quarter and has over 50 commercial discussions currently underway. The results were notably stronger than a year earlier, reflecting progress in commercialising its oncology-focused portfolio and benefiting its listed stock ONUS.